US Stock MarketDetailed Quotes

OKUR OnKure Therapeutics

Watchlist
  • 16.600
  • -0.300-1.78%
Close Nov 15 16:00 ET
  • 16.600
  • 0.0000.00%
Post 16:01 ET
221.43MMarket Cap-1747P/E (TTM)

OnKure Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
54.04%-13M
41.65%-6.47M
-133.50%-10.63M
-28.17%-34.55M
9.38M
-28.28M
-11.09M
-4.55M
-26.95M
Net income from continuing operations
116.76%6.2M
-72.79%-14.14M
-9.87%-9.54M
-19.65%-35.31M
--18.52M
---36.97M
---8.18M
---8.68M
---29.51M
Depreciation and amortization
-64.97%-259K
-4.52%148K
17.97%151K
44.70%560K
--434K
---157K
--155K
--128K
--387K
Other non cash items
--120K
----
----
----
----
----
----
---1K
----
Change In working capital
-350.97%-18.16M
285.01%5.7M
-133.91%-1.35M
-99.72%6K
---8.13M
--7.24M
---3.08M
--3.98M
--2.12M
-Change in prepaid assets
212.25%4.62M
-8,852.63%-1.7M
-22.79%437K
-350.90%-1.5M
---3.52M
--1.48M
---19K
--566K
---332K
-Change in payables and accrued expense
-473.40%-22.6M
347.63%7.46M
-150.16%-1.74M
-35.36%1.71M
---4.79M
--6.05M
---3.01M
--3.47M
--2.65M
-Change in other current liabilities
40.14%-176K
3.77%-51K
-6.38%-50K
-8.25%-210K
--184K
---294K
---53K
---47K
---194K
Cash from discontinued investing activities
Operating cash flow
54.04%-13M
41.65%-6.47M
-133.45%-10.63M
-28.17%-34.55M
--9.38M
---28.28M
---11.09M
---4.55M
---26.95M
Investing cash flow
Cash flow from continuing investing activities
309.94%61.27M
83.33%-10K
18.18%-9K
78.31%-246K
29.01M
-29.18M
-60K
-11K
-1.13M
Net PPE purchase and sale
113.60%17K
83.33%-10K
18.18%-9K
78.31%-246K
---50K
---125K
---60K
---11K
---1.13M
Cash from discontinued investing activities
Investing cash flow
309.94%61.27M
83.33%-10K
18.18%-9K
78.31%-246K
--29.01M
---29.18M
---60K
---11K
---1.13M
Financing cash flow
Cash flow from continuing financing activities
-133.37%-3.97M
293,500.00%5.87M
-99.98%10K
100.74%53.13M
-11.87M
11.89M
-2K
53.11M
26.47M
Net common stock issuance
-100.03%-20K
66.67%10K
-75.61%10K
-80.88%65K
---64.93M
--64.95M
--6K
--41K
--340K
Net preferred stock issuance
----
--0
--0
95.57%53.78M
----
----
--0
--53.78M
--27.5M
Net other financing activities
--2.05M
----
----
47.42%-723K
----
----
---8K
---716K
---1.38M
Cash from discontinued financing activities
Financing cash flow
-133.37%-3.97M
293,500.00%5.87M
-99.98%10K
100.74%53.13M
---11.87M
--11.89M
---2K
--53.11M
--26.47M
Net cash flow
Beginning cash position
-61.92%18.63M
-67.97%19.25M
158.82%29.88M
-12.32%11.54M
--11.74M
--48.93M
--60.09M
--11.54M
--13.17M
Current changes in cash
197.19%44.3M
94.49%-615K
-121.89%-10.63M
1,230.27%18.33M
--26.52M
---45.58M
---11.16M
--48.54M
---1.62M
End cash Position
417.07%60.69M
-61.92%18.63M
-67.97%19.25M
158.82%29.88M
--29.88M
--11.74M
--48.93M
--60.09M
--11.54M
Free cash flow
54.30%-12.98M
41.87%-6.48M
-133.09%-10.64M
-23.87%-34.79M
--9.33M
---28.41M
---11.15M
---4.56M
---28.09M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 54.04%-13M41.65%-6.47M-133.50%-10.63M-28.17%-34.55M9.38M-28.28M-11.09M-4.55M-26.95M
Net income from continuing operations 116.76%6.2M-72.79%-14.14M-9.87%-9.54M-19.65%-35.31M--18.52M---36.97M---8.18M---8.68M---29.51M
Depreciation and amortization -64.97%-259K-4.52%148K17.97%151K44.70%560K--434K---157K--155K--128K--387K
Other non cash items --120K---------------------------1K----
Change In working capital -350.97%-18.16M285.01%5.7M-133.91%-1.35M-99.72%6K---8.13M--7.24M---3.08M--3.98M--2.12M
-Change in prepaid assets 212.25%4.62M-8,852.63%-1.7M-22.79%437K-350.90%-1.5M---3.52M--1.48M---19K--566K---332K
-Change in payables and accrued expense -473.40%-22.6M347.63%7.46M-150.16%-1.74M-35.36%1.71M---4.79M--6.05M---3.01M--3.47M--2.65M
-Change in other current liabilities 40.14%-176K3.77%-51K-6.38%-50K-8.25%-210K--184K---294K---53K---47K---194K
Cash from discontinued investing activities
Operating cash flow 54.04%-13M41.65%-6.47M-133.45%-10.63M-28.17%-34.55M--9.38M---28.28M---11.09M---4.55M---26.95M
Investing cash flow
Cash flow from continuing investing activities 309.94%61.27M83.33%-10K18.18%-9K78.31%-246K29.01M-29.18M-60K-11K-1.13M
Net PPE purchase and sale 113.60%17K83.33%-10K18.18%-9K78.31%-246K---50K---125K---60K---11K---1.13M
Cash from discontinued investing activities
Investing cash flow 309.94%61.27M83.33%-10K18.18%-9K78.31%-246K--29.01M---29.18M---60K---11K---1.13M
Financing cash flow
Cash flow from continuing financing activities -133.37%-3.97M293,500.00%5.87M-99.98%10K100.74%53.13M-11.87M11.89M-2K53.11M26.47M
Net common stock issuance -100.03%-20K66.67%10K-75.61%10K-80.88%65K---64.93M--64.95M--6K--41K--340K
Net preferred stock issuance ------0--095.57%53.78M----------0--53.78M--27.5M
Net other financing activities --2.05M--------47.42%-723K-----------8K---716K---1.38M
Cash from discontinued financing activities
Financing cash flow -133.37%-3.97M293,500.00%5.87M-99.98%10K100.74%53.13M---11.87M--11.89M---2K--53.11M--26.47M
Net cash flow
Beginning cash position -61.92%18.63M-67.97%19.25M158.82%29.88M-12.32%11.54M--11.74M--48.93M--60.09M--11.54M--13.17M
Current changes in cash 197.19%44.3M94.49%-615K-121.89%-10.63M1,230.27%18.33M--26.52M---45.58M---11.16M--48.54M---1.62M
End cash Position 417.07%60.69M-61.92%18.63M-67.97%19.25M158.82%29.88M--29.88M--11.74M--48.93M--60.09M--11.54M
Free cash flow 54.30%-12.98M41.87%-6.48M-133.09%-10.64M-23.87%-34.79M--9.33M---28.41M---11.15M---4.56M---28.09M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSD

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data